title: Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice.
abstract: Hepatic stem cells (oval cells) proliferate within the liver after exposure to a variety of hepatic carcinogens and can generate both hepatocytes and bile duct cells. Oval cell proliferation is commonly seen in the preneoplastic stages of liver carcinogenesis, often accompanied by an inflammatory response. Tumor necrosis factor (TNF), an inflammatory cytokine, is also important in liver regeneration and hepatocellular growth. The experiments reported here explore the relationship among the TNF inflammatory pathway, liver stem cell activation, and tumorigenesis. We demonstrate that TNF is upregulated during oval cell proliferation induced by a choline-deficient, ethionine-supplemented diet and that it is expressed by oval cells. In TNF receptor type 1 knockout mice, oval cell proliferation is substantially impaired and tumorigenesis is reduced. Oval cell proliferation is impaired to a lesser extent in interleukin 6 knockout mice and is unchanged in TNF receptor type 2 knockout mice. These findings demonstrate that TNF signaling participates in the proliferation of oval cells during the preneoplastic phase of liver carcinogenesis and that loss of signaling through the TNF receptor type 1 reduces the incidence of tumor formation. The TNF inflammatory pathway may be a target for therapeutic intervention during the early stages of liver carcinogenesis.
authors: University of Western Australia, Department of Biochemistry, Nedlands WA 6907, Australia.
authors: B
authors: B
authors: Knight
authors: G C
authors: GC
authors: Yeoh
authors: K L
authors: KL
authors: Husk
authors: T
authors: T
authors: Ly
authors: L J
authors: LJ
authors: Abraham
authors: C
authors: C
authors: Yu
authors: J A
authors: JA
authors: Rhim
authors: N
authors: N
authors: Fausto
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000008:administration & dosage / Q000494:pharmacology; D002452:Cell Count; D002455:Cell Division; D002478:Cells, Cultured; D004032:Diet; D005001:Ethionine / Q000008:administration & dosage / Q000494:pharmacology; D017353:Gene Deletion; D005786:Gene Expression Regulation; D006651:Histocytochemistry; D015850:Interleukin-6 / Q000235:genetics; D008099:Liver / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D018345:Mice, Knockout; D011230:Precancerous Conditions / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction; D013234:Stem Cells / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
chemical_list: D002273:Carcinogens; D015850:Interleukin-6; D012333:RNA, Messenger; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D005001:Ethionine